Case Report

Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab

Figure 2

(a)-(b) After 3 monthly bevacizumab treatments, (c)-(d) after laser photogaoculation treatment, (e)-(f) after 4 months of aflibercept treatment, (g)-(h) after 4 months without treatment, and (i)-(j) after 4 weeks of aflibercept injection.
219792.fig.002a
(a)
219792.fig.002b
(b)
219792.fig.002c
(c)
219792.fig.002d
(d)
219792.fig.002e
(e)
219792.fig.002f
(f)
219792.fig.002g
(g)
219792.fig.002h
(h)
219792.fig.002i
(i)
219792.fig.002j
(j)